Memantine augmentation of escitalopram in treatment of executive function among patients with obsessive-compulsive disorder (OCD): a double-blind placebo-controlled randomized clinical trial.
Saved in:
| Title: | Memantine augmentation of escitalopram in treatment of executive function among patients with obsessive-compulsive disorder (OCD): a double-blind placebo-controlled randomized clinical trial. |
|---|---|
| Authors: | Mirzazadeh, Hasan1 (AUTHOR), Ghaeminia, Younes2 (AUTHOR), Mohamad Niaei, Amin3 (AUTHOR), Kamran, Mohammadsadegh4 (AUTHOR), Razeghian Jahromi, Leila1 (AUTHOR) l_razeghian@sums.ac.ir, Moshfeghinia, Reza1,5,6 (AUTHOR) rezamoshfeghinia@gmail.com |
| Source: | BMC Psychiatry. 6/2/2025, Vol. 25 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471244X |
|---|---|
| DOI: | 10.1186/s12888-025-06856-7 |
